The New England journal of medicine
-
Editorial Comment
Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.
-
Randomized Controlled Trial Multicenter Study
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
The vasoconstrictor terlipressin is used for type 1 hepatorenal syndrome (HRS-1) in many parts of the world and is part of the clinical practice guidelines in Europe. ⋯ In this trial involving adults with cirrhosis and HRS-1, terlipressin was more effective than placebo in improving renal function but was associated with serious adverse events, including respiratory failure. (Funded by Mallinckrodt Pharmaceuticals; CONFIRM ClinicalTrials.gov number, NCT02770716.).